Credit Agricole S A Decreases Holdings in Walgreens Boots Alliance, Inc. $WBA

Key Points

• Credit Agricole S A reduced its holdings in Walgreens Boots Alliance by 33.2%, selling 141,215 shares during the 1st quarter, now owning 284,028 shares valued at $3.17 million.
• Walgreens Boots Alliance reported $0.38 earnings per share for the last quarter, exceeding expectations of $0.34, with revenue of $38.99 billion up 7.2% year-over-year.
• Analysts have mixed views on Walgreens Boots Alliance, with Morgan Stanley and UBS giving it a "neutral" rating and a consensus target price of $10.59.

Credit Agricole S A trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 33.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 284,028 shares of the pharmacy operator's stock after selling 141,215 shares during the quarter. Credit Agricole S A's holdings in Walgreens Boots Alliance were worth $3,173,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. First Trust Advisors LP bought a new position in Walgreens Boots Alliance in the fourth quarter valued at about $368,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Walgreens Boots Alliance by 6.0% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 87,428 shares of the pharmacy operator's stock valued at $978,000 after purchasing an additional 4,926 shares during the last quarter. Concurrent Investment Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 28.2% in the 1st quarter. Concurrent Investment Advisors LLC now owns 13,924 shares of the pharmacy operator's stock worth $156,000 after purchasing an additional 3,064 shares during the period. Teacher Retirement System of Texas purchased a new position in shares of Walgreens Boots Alliance in the first quarter worth approximately $1,199,000. Finally, Allspring Global Investments Holdings LLC grew its position in Walgreens Boots Alliance by 3.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 42,332 shares of the pharmacy operator's stock valued at $472,000 after buying an additional 1,341 shares during the period. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $12.07 on Friday. The stock has a market cap of $10.45 billion, a PE ratio of -1.66, a price-to-earnings-growth ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $13.25. The firm has a fifty day moving average price of $11.63 and a 200-day moving average price of $11.18. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same quarter in the prior year, the firm posted $0.63 EPS. Walgreens Boots Alliance's quarterly revenue was up 7.2% compared to the same quarter last year. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

WBA has been the topic of several recent research reports. Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating on the stock. Finally, UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.